CRBU
Price
$2.29
Change
-$0.08 (-3.38%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
212.05M
17 days until earnings call
FATE
Price
$1.24
Change
-$0.01 (-0.80%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
142.14M
4 days until earnings call
Interact to see
Advertisement

CRBU vs FATE

Header iconCRBU vs FATE Comparison
Open Charts CRBU vs FATEBanner chart's image
Caribou Biosciences
Price$2.29
Change-$0.08 (-3.38%)
Volume$10.89K
Capitalization212.05M
Fate Therapeutics
Price$1.24
Change-$0.01 (-0.80%)
Volume$8.97K
Capitalization142.14M
CRBU vs FATE Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. FATE commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FATE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CRBU: $2.28 vs. FATE: $1.24)
Brand notoriety: CRBU and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 104% vs. FATE: 57%
Market capitalization -- CRBU: $212.05M vs. FATE: $142.14M
CRBU [@Biotechnology] is valued at $212.05M. FATE’s [@Biotechnology] market capitalization is $142.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than FATE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while FATE’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 4 bearish.
  • FATE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FATE is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а +11.22% price change this week, while FATE (@Biotechnology) price change was +9.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

FATE is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($212M) has a higher market cap than FATE($142M). CRBU YTD gains are higher at: 43.396 vs. FATE (-24.848). CRBU has higher annual earnings (EBITDA): -159.14M vs. FATE (-168.28M). FATE has more cash in the bank: 240M vs. CRBU (208M). CRBU has less debt than FATE: CRBU (26.2M) vs FATE (83.3M). FATE has higher revenues than CRBU: FATE (13.3M) vs CRBU (9.92M).
CRBUFATECRBU / FATE
Capitalization212M142M149%
EBITDA-159.14M-168.28M95%
Gain YTD43.396-24.848-175%
P/E RatioN/AN/A-
Revenue9.92M13.3M75%
Total Cash208M240M87%
Total Debt26.2M83.3M31%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFATE
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTLFF0.180.03
+18.76%
Metallis Resources, Inc.
ARHUF25.80N/A
N/A
AAK AB
NWHUF3.59N/A
N/A
Northwest Healthcare Properties Real Estate Investment
SSUMF26.75N/A
N/A
Sumitomo Corp.
TEUTF0.66-0.01
-1.49%
Teuton Resources Corp.

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-3.80%
CRSP - CRBU
63%
Loosely correlated
-1.97%
BEAM - CRBU
56%
Loosely correlated
+3.68%
RXRX - CRBU
54%
Loosely correlated
+3.67%
NTLA - CRBU
53%
Loosely correlated
+6.38%
FATE - CRBU
53%
Loosely correlated
-0.80%
More